PMID- 26940296
OWN - NLM
STAT- MEDLINE
DCOM- 20170809
LR  - 20170817
IS  - 1097-6779 (Electronic)
IS  - 0016-5107 (Linking)
VI  - 84
IP  - 1
DP  - 2016 Jul
TI  - Screening and surveillance for gastric cancer in the United States: Is it needed?
PG  - 18-28
LID - 10.1016/j.gie.2016.02.028 [doi]
LID - S0016-5107(16)00217-0 [pii]
AB  - BACKGROUND AND AIMS: Although the incidence of gastric cancer in the United
      States is relatively low, the incidence of gastric cancer is higher than for
      esophageal cancer, for which clear guidelines for screening and surveillance
      exist. With the increasing availability of endoscopic therapy, such as endoscopic
      submucosal dissection, for treating advanced dysplasia and early gastric cancer, 
      establishing guidelines for screening and surveillance of patients who are at
      high risk of developing gastric cancer has the potential to diagnose and treat
      gastric cancer at an earlier stage and improve mortality from gastric cancer. The
      aims of this article were to review the data regarding the risk factors for
      developing gastric cancer, methods for gastric cancer screening, and results of
      national screening programs. METHODS: A review of the existing literature related
      to the aims was performed. RESULTS: Risk factors for gastric cancer that were
      identified include race/ethnicity (East Asian, Russian, or South American),
      first-degree relative diagnosed with gastric cancer, positive Helicobacter pylori
      status, and presence of atrophic gastritis or intestinal metaplasia. Endoscopy
      has the highest rate of detecting gastric cancer compared with other gastric
      cancer screening methods. The national screening program in Japan has
      demonstrated a mortality reduction from gastric cancer based on cohort data.
      CONCLUSIONS: Gastric cancer screening with endoscopy should be considered in
      individuals who are immigrants from regions associated with a high risk of
      gastric cancer (East Asia, Russia, or South America) or who have a family history
      of gastric cancer. Those with findings of atrophic gastritis or intestinal
      metaplasia on screening endoscopy should undergo surveillance endoscopy every 1
      to 2 years. Large prospective multicenter studies are needed to further identify 
      additional risk factors for developing gastric cancer and to assess whether
      gastric cancer screening programs for high-risk populations in the United States 
      would result in improved mortality.
CI  - Copyright (c) 2016 American Society for Gastrointestinal Endoscopy. Published by 
      Elsevier Inc. All rights reserved.
FAU - Kim, Gwang Ha
AU  - Kim GH
AD  - Department of Internal Medicine, Pusan National University School of Medicine and
      Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
FAU - Liang, Peter S
AU  - Liang PS
AD  - Division of Gastroenterology, Department of Medicine, University of Washington,
      Seattle, Washington, USA.
FAU - Bang, Sung Jo
AU  - Bang SJ
AD  - Department of Internal Medicine, Ulsan University Hospital, University of Ulsan
      College of Medicine, Ulsan, Korea.
FAU - Hwang, Joo Ha
AU  - Hwang JH
AD  - Division of Gastroenterology, Department of Medicine, University of Washington,
      Seattle, Washington, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160303
PL  - United States
TA  - Gastrointest Endosc
JT  - Gastrointestinal endoscopy
JID - 0010505
SB  - IM
MH  - Asian Americans
MH  - Early Detection of Cancer/*methods
MH  - Ethnic Groups
MH  - Far East/ethnology
MH  - Gastritis, Atrophic/epidemiology
MH  - Gastroscopy/*methods
MH  - Helicobacter Infections/epidemiology
MH  - Helicobacter pylori
MH  - Hispanic Americans
MH  - Humans
MH  - Incidence
MH  - Metaplasia/epidemiology
MH  - Russia/ethnology
MH  - South America/ethnology
MH  - Stomach/pathology
MH  - Stomach Neoplasms/*diagnosis/epidemiology/ethnology
MH  - United States/epidemiology
EDAT- 2016/03/05 06:00
MHDA- 2017/08/10 06:00
CRDT- 2016/03/05 06:00
PHST- 2015/11/24 00:00 [received]
PHST- 2016/02/19 00:00 [accepted]
PHST- 2016/03/05 06:00 [entrez]
PHST- 2016/03/05 06:00 [pubmed]
PHST- 2017/08/10 06:00 [medline]
AID - S0016-5107(16)00217-0 [pii]
AID - 10.1016/j.gie.2016.02.028 [doi]
PST - ppublish
SO  - Gastrointest Endosc. 2016 Jul;84(1):18-28. doi: 10.1016/j.gie.2016.02.028. Epub
      2016 Mar 3.